240 related articles for article (PubMed ID: 8391429)
1. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
Burris TP; Freeman ME
Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
Wang J; Ciofi P; Crowley WR
Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
Burris TP; Freeman ME
Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
[TBL] [Abstract][Full Text] [Related]
4. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
Burris TP; Nguyen DN; Smith SG; Freeman ME
Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
[TBL] [Abstract][Full Text] [Related]
5. Single cell monitoring of cytosolic calcium reveals subtypes of rat lactotrophs with distinct responses to dopamine and thyrotropin-releasing hormone.
Winiger BP; Wuarin F; Zahnd GR; Wollheim CB; Schlegel W
Endocrinology; 1987 Dec; 121(6):2222-8. PubMed ID: 3119314
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
7. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
9. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
Mau SE
J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
[TBL] [Abstract][Full Text] [Related]
10. Dopamine withdrawal elicits prolonged calcium rise to support prolactin rebound release.
Ho MY; Kao JP; Gregerson KA
Endocrinology; 1996 Aug; 137(8):3513-21. PubMed ID: 8754781
[TBL] [Abstract][Full Text] [Related]
11. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine.
Cui ZJ; Gorelick FS; Dannies PS
Endocrinology; 1994 May; 134(5):2245-50. PubMed ID: 8156928
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid increases cytosolic calcium and stimulates hormone release in rat lactotrophs.
Roudbaraki MM; Vacher P; Drouhault R
Am J Physiol; 1995 Jun; 268(6 Pt 1):E1215-23. PubMed ID: 7611398
[TBL] [Abstract][Full Text] [Related]
15. TRH raises cytosolic Ca2+ in human adenomatous lactotrophs.
Spada A; Reza-Elahi F; Lania A
J Endocrinol Invest; 1990 Jan; 13(1):13-8. PubMed ID: 2108197
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity.
Kineman RD; Gettys TW; Frawley LS
Endocrinology; 1994 Aug; 135(2):790-3. PubMed ID: 8033828
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
19. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
Kineman RD; Gettys TW; Frawley LS
J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
[TBL] [Abstract][Full Text] [Related]
20. The cortical actin cytoskeleton of lactotropes as an intracellular target for the control of prolactin secretion.
Carbajal ME; Vitale ML
Endocrinology; 1997 Dec; 138(12):5374-84. PubMed ID: 9389523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
